Skip to Content

Tilray Brands Inc

TLRY: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$9.00QhnmZsyhrwjv

We Don't See Much Synergy Across Tilray's Portfolio of Businesses or a Logical US Cannabis Entry

Business Strategy and Outlook

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a reverse merger and taking the target name in 2021.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of TLRY so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center